Stay updated on ARGX-113 in Myasthenia Gravis: Safety Trial

Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-113 in Myasthenia Gravis: Safety Trial page

  1. Check
    today
    Change Detected
    Summary
    The study record no longer lists the U.S. NIH grant/contract identifier “2018,” and the site revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T18:08:58.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The study record for the ARGX-113 follow-on trial in generalized myasthenia gravis is displayed, including its eligibility criteria, locations, design, outcomes, results-related dates, and study documents.
    Difference
    66%
    Check dated 2026-11-08T00:27:06.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T18:27:00.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A banner announces that NIH content is transitioning from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-24T19:22:57.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T20:28:47.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study page is showing a 403 Forbidden response instead of its study content.
    Difference
    0.2%
    Check dated 2026-10-10T20:43:35.000Z thumbnail image

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Safety Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.